Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
indicates upregulation (increase)
Recalls & Warnings January 11, 2002 Canada Requests Recall of Certain Ephedra/Ephedrine Products OTTAWA - January 10, 2002 - Health Canada is requesting a recall from the market of certain products containing Ephedra/ephedrine after a risk assessment concluded that these products pose a serious risk to health
Most analysts expect a filing in late 2027 at the earliest, with potential approval in 2028
Diabetic patients at moderate or high risk require the involvement of a foot care specialist for further examination and surveillance
US$ 27.69
US$ 29.13
US$ 21.46
US$ 22.33
US$ 25.81
US$ 22.00
US$ 28.22
